Sk Biopharmaceuticals Co., Ltd.

Samsung Electronics Co., Ltd.

Eun Ju Choi

Ju Young Lee

Ji Won Lee

Ji Yeon Kim

Chan Mi Joung

Young Koo Jang

Cheol Young Maeng

Nahm Ryune Cho

Hye Kyung Min

Jin Yong Chung

Yong Je Shin

Yu Jin Shin

Hyo Jun Jung

Eun Ju Ryu

Jong Sil Park

Seung Mo Ham

Chun Eung Park

Seung Nam Han

Soo Bong Cha

Yong Gil Kim

Yeo Jin Yoon

Jin Sung Kim

Myung Jin Jung

Young-Ho Park

Yonghwa Lee

Seontaek Kim

Yong Soo Kim

Yu Jin Kim

Young Soon Kang

Hee Jeong Lim

Choon Ho Ryu

Min Soo Han

Eun Hee Baek

Jesuk Yeon

Ka Eun Lee

Yea Mi Song

Chang Hwan Kim

Young-Sik Lee

Hye Won Shin

Sung Jin Moon

A storage device includes a nonvolatile memory device; and a controller configured to, sequentially receive first read commands and a first write command, the first write command being associated with first write data, slice the first write command to generate a plurality of sub-commands, slice the first write data to generate a plurality of sub-data elements, and alternately transmit, to the nonvolatile memory device, at least one read command of the first read commands, and one sub-command of the plurality of sub-commands and one sub-data element of the plurality of sub-data elements.

Storage device including nonvolatile memory device and controller, controller and operating method of nonvolatile memory device

Disclosed are oxadiazole compounds and pharmaceutically acceptable salts thereof. The compounds and pharmaceutically acceptable salts thereof are specifically suitable for the treatment of neurological diseases such as epilepsy.

Compound having oxadiazole and pharmaceutical composition containing the same

The present invention relates to a use for the purpose of preventing, alleviating, or treating status epilepticus by administering a medicament or pharmaceutical composition comprising a carbamate compound of chemical formula 1.

Use of carbamate compound for prevention, alleviation or treatment of status epilepticus

The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same

A storage device and an operating method thereof are provided. Provided is a storage device including, a memory cell, and a storage controller which includes a flash controller that performs a data operation on the memory cell, and a processor that executes an RTOS (Real Time Operating System) for controlling the flash controller, wherein the RTOS communicates with the storage controller and operates in a normal operation mode, the RTOS generates a snapshot data in a debug mode when a defect occurs, the RTOS switches to the debug mode through context switching in the normal operation mode, and the RTOS operates in the normal operation mode, when an urgent work occurs, while performing an operation of generating the snapshot data in the debug mode.

Storage device and operating method thereof

The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same:  The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Growing community of inventors

Daejeon, South Korea

Eun Ju Choi